Li Gao

Li Gao

Auto-generated profile, based on publicly available information

Li Gao

Department of Obstetrics and Gynecology, The People’s Hospital of Yingshang, Anhui, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2020 in Future Oncology
Verified
Journal Article
Open access
WMWeipu Mao
Weipu Mao
SWShaomin Wei
Shaomin Wei
HYHui Yang
Hui Yang
QYQianqian Yu
Qianqian Yu
MXMei Xu
Mei Xu
LGLi Gao
Li Gao
Aim: Our aim was to analyze the clinicopathological features of lung, liver, bone and brain metastasis in patients with endometrial cancer (EC). Patients & methods: We screened patients diagnosed w...

1 October 2009 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
LXLiwei Xie
Liwei Xie
YSY. Shao
Y. Shao
YHY. Hu
Y. Hu
HLHui-Min Li
Hui-Min Li
LGL. Gao
L. Gao
HHHai Hu
Hai Hu

1 January 2021 in Bosnian Journal of Basic Medical Sciences
Verified
Journal Article
Open access
PDF file
QLQunlong Liu
Qunlong Liu
WLWenxia Li
Wenxia Li
MXMing Xie
Ming Xie
MYMing Yang
Ming Yang
MXMei Xu
Mei Xu
LGLi Gao
Li Gao
In this study, we established a nomogram for the prognostic prediction of patients with early-onset cervical cancer (EOCC) for both overall survival (OS) and cancer-specific survival (CSS). The Surveillance, Epidemiology, and End Results (SEER) database was used to identify 10,079 patients diagnosed with EOCC between 2004 and 2015; these cases were then randomly divided into training and validation sets. The independent prognostic factors were identified in a retrospective study of 7,055 patients from the training set. A prognostic nomogram was developed using R software according to the results of multivariable Cox regression analysis. Furthermore, the model was externally validated using the data from the remaining 3,024 patients diagnosed at different times and enrolled in the SEER database. For the training set, the C-indexes for OS and CSS prediction were determined to be 0.831 (95 % confidence interval [CI]: 0.815-0.847) and 0.855 (95 % CI: 0.839-0.871), respectively. Receiver operating characteristic (ROC) analysis has revealed that the nomograms were a superior predictor compared with TNM stage and SEER stage. The areas under the curve (AUC) of the nomogram for OS and CSS prediction in the ROC analysis were 0.855 (95 % CI: 0.847-0.864) and 0.782 (95 % CI: 0.760-0.804), respectively. In addition, calibration curves indicated a perfect agreement between the nomogram-predicted and the actual 1-, 3-, and 5-year OS and CSS rates in the validation cohort. Thus, in this study, we established and validated a prognostic nomogram that provides an accurate prediction for 3-, 5-, and 10-year OS and CSS of EOCC patients. This will be useful for clinicians in guiding counseling and clinical trial design for cervical cancer patients.

1 January 2018 in Cancer Biology & Medicine
Verified
Journal Article
Open access
PDF file
MGMing Gao
Ming Gao
GMGe Minghua
Ge Minghua
QJQing-Hai Ji
Qing-Hai Ji
RCRuochuan Cheng
Ruochuan Cheng
LHLu Hankui
Lu Hankui
ZXZhengang Xu
Zhengang Xu
2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer

1 November 2021 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
RWR.Y. Wu
R.Y. Wu
LGL. Gao
L. Gao
XHX. Huang
X. Huang
JXJ. Xiao
J. Xiao
KWK. Wang
K. Wang
JYJun-Lin Yi
Jun-Lin Yi

22 November 2024 in Annals of Medicine
Verified
Journal Article
Open access
YGYongzhe Gu
Yongzhe Gu
YLYangyang Li
Yangyang Li
LGLi Gao
Li Gao
Previous studies revealed that the elevation of serum tumor markers (TMs) can serve as a prognostic indicator for diseases other than cancer, but little is known about its association with acute ischemic stroke (AIS). Based on a series of molecular markers and gene pathways shared in both stroke and cancer, we aimed to investigate whether the elevation of TMs could predict clinical outcomes after AIS. Patients diagnosed with AIS were enrolled and classified into the elevated TMs group and the non-elevated TMs group according to whether any TMs were elevated or not. Then they were followed up 6 months to assess clinical outcomes. Poor functional outcomes were defined as modified Rankin Scale (mRS) > 2 points. 289 AIS patients were finally enrolled, of which 197 (68.2%) were classified as the elevated TMs group. Patients in the elevated TMs group were more likely (OR = 2.384; p = 0.005) to have poor functional outcomes at follow-up than those in the non-elevated TMs group. However, no specific TM was significantly more elevated than the other TMs in the patients with poor functional outcome. The combination of TMs was more sensitive than individual TM in terms of prognosis prediction. Furthermore, rather than the number of elevated items, whether any TM was elevated or not was the most appropriate discriminator for functional outcomes after AIS. Elevation of TMs may indicate poor functional outcomes after AIS. Consequently, AIS patients with elevated TMs required close clinical monitoring and intensified treatment.